This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Irisys, Inc.. Active years: 2021.
Company Filing History:
Years Active: 2021
Title: The Innovative Contributions of Robert Giannini
Introduction
Robert Giannini is a notable inventor based in San Diego, California. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on liposomal anticancer compositions, which have the potential to improve therapeutic outcomes for cancer patients.
Latest Patents
Giannini holds a patent for "Liposomal anticancer compositions." This patent includes methods and compositions for the treatment of cancer. The invention describes liposome encapsulated chemotherapeutic agents, which encompass a weakly basic anticancer compound and an acid or salt thereof. The acids mentioned in the patent are oxalic acid or tartaric acid, along with methods for preparing and utilizing these compositions.
Career Highlights
Robert Giannini is associated with Irisys, Inc., where he continues to advance his research in cancer therapies. His dedication to innovation in this field has led to the development of effective treatment methods that could benefit many patients.
Collaborations
Giannini has collaborated with notable colleagues, including Igor Nikoulin and Yevgeniya Plekhov. These partnerships have fostered a collaborative environment that enhances the research and development of new cancer treatment methodologies.
Conclusion
Robert Giannini's work in liposomal anticancer compositions represents a significant advancement in cancer treatment. His innovative approach and collaboration with other experts in the field highlight the importance of teamwork in scientific research.